Logo image of USM

US CELLULAR CORP (USM) Stock Fundamental Analysis

NYSE:USM - New York Stock Exchange, Inc. - US9116841084 - Common Stock - Currency: USD

61.8  +0.77 (+1.26%)

After market: 61.8 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to USM. USM was compared to 21 industry peers in the Wireless Telecommunication Services industry. While USM seems to be doing ok healthwise, there are quite some concerns on its profitability. USM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

USM had positive earnings in the past year.
USM had a positive operating cash flow in the past year.
Of the past 5 years USM 4 years were profitable.
In the past 5 years USM always reported a positive cash flow from operatings.
USM Yearly Net Income VS EBIT VS OCF VS FCFUSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

USM has a Return On Assets of -0.38%. This is in the lower half of the industry: USM underperforms 71.43% of its industry peers.
USM has a worse Return On Equity (-0.85%) than 71.43% of its industry peers.
USM's Return On Invested Capital of 1.10% is on the low side compared to the rest of the industry. USM is outperformed by 76.19% of its industry peers.
The Average Return On Invested Capital over the past 3 years for USM is significantly below the industry average of 6.26%.
The 3 year average ROIC (1.05%) for USM is below the current ROIC(1.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROIC 1.1%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
USM Yearly ROA, ROE, ROICUSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

The Operating Margin of USM (3.58%) is worse than 76.19% of its industry peers.
USM's Operating Margin has improved in the last couple of years.
USM has a Gross Margin (57.26%) which is comparable to the rest of the industry.
USM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.58%
PM (TTM) N/A
GM 57.26%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
USM Yearly Profit, Operating, Gross MarginsUSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so USM is destroying value.
Compared to 1 year ago, USM has about the same amount of shares outstanding.
Compared to 5 years ago, USM has less shares outstanding
USM has a better debt/assets ratio than last year.
USM Yearly Shares OutstandingUSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
USM Yearly Total Debt VS Total AssetsUSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

USM has an Altman-Z score of 1.39. This is a bad value and indicates that USM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.39, USM is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
USM has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as USM would need 8.09 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.09, USM is in line with its industry, outperforming 42.86% of the companies in the same industry.
A Debt/Equity ratio of 0.62 indicates that USM is somewhat dependend on debt financing.
USM's Debt to Equity ratio of 0.62 is in line compared to the rest of the industry. USM outperforms 57.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Altman-Z 1.39
ROIC/WACC0.15
WACC7.53%
USM Yearly LT Debt VS Equity VS FCFUSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

2.3 Liquidity

USM has a Current Ratio of 1.70. This is a normal value and indicates that USM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.70, USM is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
USM has a Quick Ratio of 1.48. This is a normal value and indicates that USM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.48, USM is doing good in the industry, outperforming 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.48
USM Yearly Current Assets VS Current LiabilitesUSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.46% over the past year.
USM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.19% yearly.
Looking at the last year, USM shows a decrease in Revenue. The Revenue has decreased by -4.11% in the last year.
The Revenue has been decreasing by -1.29% on average over the past years.
EPS 1Y (TTM)7.46%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%5%
Revenue 1Y (TTM)-4.11%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-6.21%

3.2 Future

USM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.56% yearly.
Based on estimates for the next years, USM will show a decrease in Revenue. The Revenue will decrease by -0.31% on average per year.
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y-3.08%
EPS Next 5Y31.56%
Revenue Next Year-2.92%
Revenue Next 2Y-1.18%
Revenue Next 3Y-0.75%
Revenue Next 5Y-0.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USM Yearly Revenue VS EstimatesUSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
USM Yearly EPS VS EstimatesUSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 85.83, USM can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of USM indicates a slightly more expensive valuation: USM is more expensive than 71.43% of the companies listed in the same industry.
USM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.68.
With a Price/Forward Earnings ratio of 55.63, USM can be considered very expensive at the moment.
USM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. USM is more expensive than 71.43% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of USM to the average of the S&P500 Index (22.50), we can say USM is valued expensively.
Industry RankSector Rank
PE 85.83
Fwd PE 55.63
USM Price Earnings VS Forward Price EarningsUSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, USM is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
USM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. USM is more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.88
EV/EBITDA 9.96
USM Per share dataUSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USM's earnings are expected to decrease with -3.08% in the coming years. This may justify a cheaper valuation.
PEG (NY)5.39
PEG (5Y)N/A
EPS Next 2Y25.09%
EPS Next 3Y-3.08%

0

5. Dividend

5.1 Amount

USM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

US CELLULAR CORP

NYSE:USM (5/16/2025, 8:04:00 PM)

After market: 61.8 0 (0%)

61.8

+0.77 (+1.26%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners26.28%
Inst Owner Change1.77%
Ins Owners0.56%
Ins Owner Change30.88%
Market Cap5.25B
Analysts75.56
Price Target75.59 (22.31%)
Short Float %6.68%
Short Ratio3.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)76.69%
Min EPS beat(2)-39.44%
Max EPS beat(2)192.83%
EPS beat(4)3
Avg EPS beat(4)73.51%
Min EPS beat(4)-39.44%
Max EPS beat(4)192.83%
EPS beat(8)5
Avg EPS beat(8)113.75%
EPS beat(12)6
Avg EPS beat(12)56.53%
EPS beat(16)8
Avg EPS beat(16)47.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-5.4%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.4%
Min Revenue beat(4)-5.4%
Max Revenue beat(4)-0.57%
Revenue beat(8)1
Avg Revenue beat(8)-2.52%
Revenue beat(12)3
Avg Revenue beat(12)-2.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.08%
PT rev (1m)0.51%
PT rev (3m)-4.44%
EPS NQ rev (1m)-19.55%
EPS NQ rev (3m)-10.61%
EPS NY rev (1m)-28.09%
EPS NY rev (3m)-25.4%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-1.15%
Valuation
Industry RankSector Rank
PE 85.83
Fwd PE 55.63
P/S 1.42
P/FCF 14.88
P/OCF 6.25
P/B 1.15
P/tB 1313.25
EV/EBITDA 9.96
EPS(TTM)0.72
EY1.17%
EPS(NY)1.11
Fwd EY1.8%
FCF(TTM)4.15
FCFY6.72%
OCF(TTM)9.88
OCFY15.99%
SpS43.66
BVpS53.94
TBVpS0.05
PEG (NY)5.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.38%
ROE -0.85%
ROCE 1.39%
ROIC 1.1%
ROICexc 1.12%
ROICexgc 2.19%
OM 3.58%
PM (TTM) N/A
GM 57.26%
FCFM 9.51%
ROA(3y)0.13%
ROA(5y)0.85%
ROE(3y)0.32%
ROE(5y)1.91%
ROIC(3y)1.05%
ROIC(5y)1.3%
ROICexc(3y)1.07%
ROICexc(5y)1.37%
ROICexgc(3y)2.08%
ROICexgc(5y)2.45%
ROCE(3y)1.33%
ROCE(5y)1.64%
ROICexcg growth 3Y-6.62%
ROICexcg growth 5Y1.42%
ROICexc growth 3Y-9.23%
ROICexc growth 5Y-3.33%
OM growth 3Y-6.02%
OM growth 5Y3.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y0.4%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 8.09
Debt/EBITDA 3.55
Cap/Depr 73.45%
Cap/Sales 13.12%
Interest Coverage 250
Cash Conversion 105.53%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.48
Altman-Z 1.39
F-Score5
WACC7.53%
ROIC/WACC0.15
Cap/Depr(3y)121.94%
Cap/Depr(5y)166.9%
Cap/Sales(3y)20.71%
Cap/Sales(5y)28.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.46%
EPS 3Y-26.25%
EPS 5Y-13.19%
EPS Q2Q%5%
EPS Next Y15.94%
EPS Next 2Y25.09%
EPS Next 3Y-3.08%
EPS Next 5Y31.56%
Revenue 1Y (TTM)-4.11%
Revenue growth 3Y-2.93%
Revenue growth 5Y-1.29%
Sales Q2Q%-6.21%
Revenue Next Year-2.92%
Revenue Next 2Y-1.18%
Revenue Next 3Y-0.75%
Revenue Next 5Y-0.31%
EBIT growth 1Y-23.56%
EBIT growth 3Y-8.78%
EBIT growth 5Y2.21%
EBIT Next Year20757.2%
EBIT Next 3Y484.74%
EBIT Next 5Y183.49%
FCF growth 1Y406.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.47%
OCF growth 3Y3.26%
OCF growth 5Y4.05%